Rock Creek Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2015. For the period, the company reported that operating loss from operations was $3.82 million, compared to an operating loss from operations of $9.69 million for the same quarter ended March 31, 2014. Loss from continuing operations before income taxes was $297,000, compared to a loss from continuing operations before income taxes of $9.69 million for the same quarter ended March 31, 2014.